Published in Cancer Biomark on June 07, 2012
Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers. Am J Cancer Res (2016) 0.75
Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol (2006) 7.21
Cohort profile: the study of health in Pomerania. Int J Epidemiol (2010) 4.38
Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev (2010) 3.67
RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity (2011) 3.53
Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res (2009) 3.25
Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol (2007) 2.82
Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol (2003) 2.80
Rehabilitation in Patients With Coronary Heart Disease: Participation and Its Effect on Prognosis. Dtsch Arztebl Int (2015) 2.69
Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol (2007) 2.36
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med (2009) 2.28
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol (2011) 2.23
Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery (2004) 2.18
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA (2009) 2.10
EuroSCORE directed intraaortic balloon pump placement in high-risk patients undergoing cardiac surgery--retrospective analysis of 267 patients. Interact Cardiovasc Thorac Surg (2008) 2.09
Is the mediastinal lymphadenectomy during pulmonary metastasectomy of colorectal cancer necessary? Interact Cardiovasc Thorac Surg (2010) 2.08
Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem (2006) 1.91
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. J Am Coll Cardiol (2002) 1.81
Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol (2011) 1.76
Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev (2003) 1.72
IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med (2008) 1.71
Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev (2006) 1.69
Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol (2005) 1.60
Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin. Cancer Biol Ther (2008) 1.58
A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci U S A (2005) 1.55
Modeling lymphangiogenesis in a three-dimensional culture system. Nat Methods (2008) 1.55
The treatment of pleural carcinosis with malignant pleural effusion. Dtsch Arztebl Int (2013) 1.51
Anti-angiogenic therapies for metastatic colorectal cancer. Cochrane Database Syst Rev (2009) 1.49
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab (2010) 1.49
Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev (2009) 1.49
CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur J Cancer (2005) 1.46
Carotid to femoral pulse wave velocity reflects the extent of coronary artery disease. J Clin Hypertens (Greenwich) (2014) 1.42
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J (2003) 1.42
The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol Microbiol (2005) 1.40
Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis (2004) 1.39
Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol (2007) 1.38
N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology (2007) 1.37
HSP70 protects against TNF-induced lethal inflammatory shock. Immunity (2002) 1.37
Cumulative occupational lumbar load and lumbar disc disease--results of a German multi-center case-control study (EPILIFT). BMC Musculoskelet Disord (2009) 1.36
Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J (2004) 1.34
Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord (2005) 1.33
Potential biomarkers of ageing. Biol Chem (2008) 1.33
How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol Cell Endocrinol (2012) 1.30
New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology (2013) 1.29
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J Immunol (2005) 1.29
Extracorporeal lung support in trauma patients with severe chest injury and acute lung failure: a 10-year institutional experience. Crit Care (2013) 1.26
The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production. Proc Natl Acad Sci U S A (2006) 1.25
Type I interferon drives tumor necrosis factor-induced lethal shock. J Exp Med (2009) 1.25
Cardiac surgery in the elderly patient. Dtsch Arztebl Int (2009) 1.24
Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006. Eur J Epidemiol (2009) 1.22
Inflammation: A nervous connection. Nature (2003) 1.21
Prevention and health promotion in undergraduate medical education: Preferences, attitudes and previous knowledge of medical students - a cross-sectional study. GMS Z Med Ausbild (2011) 1.18
Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med (2013) 1.17
Risk factors for mediastinitis after cardiac surgery - a retrospective analysis of 1700 patients. J Cardiothorac Surg (2007) 1.17
Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. Cytokine Growth Factor Rev (2011) 1.17
In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatography. Mol Cell Proteomics (2009) 1.16
On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic (2011) 1.16
Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol (2002) 1.15
Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes (2008) 1.14
Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res (2005) 1.14
Neuregulin receptors erbB2 and erbB4 in failing human myocardium -- depressed expression and attenuated activation. Basic Res Cardiol (2005) 1.13
N-glycomic changes in serum proteins during human aging. Rejuvenation Res (2007) 1.13
Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer. Cochrane Database Syst Rev (2012) 1.12
Thirty years of Mus spretus: a promising future. Trends Genet (2009) 1.12
Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J (2011) 1.10
N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res Rev (2012) 1.10
Descending necrotizing mediastinitis: early detection and radical surgery are crucial. J Oral Maxillofac Surg (2007) 1.09
Serum N-glycan profile shift during human ageing. Exp Gerontol (2010) 1.08
Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice. Cytokine (2008) 1.07
Minimally invasive vacuum-assisted closure therapy in the management of complex pleural empyema. Interact Cardiovasc Thorac Surg (2013) 1.05
Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications. Clin Res Cardiol (2011) 1.04
Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience. Eur J Cardiothorac Surg (2012) 1.04
Matrix metalloproteinases as drug targets in ischemia/reperfusion injury. Drug Discov Today (2011) 1.04
Increased spreading, Rac/p21-activated kinase (PAK) activity, and compromised cell motility in cells deficient in vasodilator-stimulated phosphoprotein (VASP). J Biol Chem (2002) 1.04
Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases. J Neurosci (2012) 1.04
Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J Clin Invest (2012) 1.03
Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer (2005) 1.02
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study. Clin Res Cardiol (2012) 1.02
S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. Eur J Cancer (2007) 1.01